NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Emory University
Conditions: Human Papilloma Virus, Human Papilloma Virus Vaccine
Interventions: CDC 4 Pillars Program
Countries: United States
People living with HIV (PLWH) are 28 times more likely to be diagnosed with Human Papillomavirus (HPV) - associated anal cancer than the general population. The HPV vaccine is an effective and safe approach to prevent and reduce the risk of HPV-related disease among PLWH. HPV vaccine programs tailored and implemented in the HIV population are lagging for this high-risk group. The CDC's 4 Pillars Transformation Program is a multi-level, evidence-based intervention that has been successfully used to increase HPV vaccination in the general population and is ready to be tested in the high-risk HIV population, particularly PLWH in the rural South. This program offers providers and clinic staff evidence-based strategies to increase HPV vaccination uptake via training and educational resources. This study proposes to tailor and refine the 4 Pillars Program and conduct this project in three HIV clinics in Georgia.
Sex: ALL
Age: 18 Years to 45 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria * HIV positive * 18-45 years of age * Can read and speak English * Capable of providing informed consent * Has not previously received three series HPV vaccine * No contraindications to receiving HPV vaccine (i.e. history of anaphylactic allergy to later, an immediate hypersensitivity to yeast, current moderate or severe acute illness, and/or are currently pregnant). Exclusion Criteria: * Has contraindications to receiving the HPV vaccine i.e., history of an anaphylactic allergy to latex, an immediate hypersensitivity to yeast, current moderate or severe acute illness, and/or are currently pregnant)
- Albany, Georgia, United States
- Atlanta, Georgia, United States
- Atlanta, Georgia, United States
- Lithonia, Georgia, United States